ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04080	Neuroactive ligand-receptor interaction	141/967	423/7206	1.6312290234e-27
ko04721	Synaptic vesicle cycle	52/967	80/7206	8.85566679368e-27
ko04724	Glutamatergic synapse	71/967	152/7206	6.72821639996e-24
ko05033	Nicotine addiction	40/967	56/7206	3.04090480287e-23
ko04727	GABAergic synapse	52/967	110/7206	4.49863453052e-18
ko05032	Morphine addiction	51/967	110/7206	2.69495282695e-17
ko04713	Circadian entrainment	57/967	136/7206	1.1166413156e-16
ko04728	Dopaminergic synapse	68/967	185/7206	4.17548552802e-16
ko04725	Cholinergic synapse	59/967	160/7206	3.39133910045e-14
ko04723	Retrograde endocannabinoid signaling	60/967	175/7206	8.44703926824e-13
ko04024	cAMP signaling pathway	78/967	279/7206	6.63049241726e-11
ko04742	Taste transduction	29/967	61/7206	1.01787337886e-10
ko04911	Insulin secretion	41/967	117/7206	1.79491257211e-09
ko04744	Phototransduction	20/967	36/7206	2.59225114639e-09
ko04360	Axon guidance	64/967	233/7206	7.05526324236e-09
ko04726	Serotonergic synapse	44/967	137/7206	1.23085411946e-08
ko04261	Adrenergic signaling in cardiomyocytes	58/967	205/7206	1.4871807645e-08
ko05031	Amphetamine addiction	33/967	91/7206	2.66941340171e-08
ko03040	Spliceosome	1/967	145/7206	3.86029667115e-08
ko04966	Collecting duct acid secretion	15/967	26/7206	1.35313882039e-07
ko05030	Cocaine addiction	27/967	73/7206	3.10812620481e-07
ko05168	Herpes simplex infection	5/967	182/7206	1.28547818009e-06
ko04720	Long-term potentiation	32/967	99/7206	1.47047692429e-06
ko05014	Amyotrophic lateral sclerosis (ALS)	26/967	74/7206	1.6153125988e-06
ko04921	Oxytocin signaling pathway	53/967	209/7206	2.49383158894e-06
ko04970	Salivary secretion	30/967	95/7206	4.40489814881e-06
ko04060	Cytokine-cytokine receptor interaction	7/967	191/7206	7.50769394454e-06
ko03013	RNA transport	5/967	166/7206	7.95423517909e-06
ko05203	Viral carcinogenesis	15/967	277/7206	1.94203577502e-05
ko05164	Influenza A	6/967	167/7206	2.68732085517e-05
ko04120	Ubiquitin mediated proteolysis	4/967	138/7206	3.92111145063e-05
ko05110	Vibrio cholerae infection	21/967	63/7206	4.01212308785e-05
ko04260	Cardiac muscle contraction	28/967	98/7206	6.68814325572e-05
ko04621	NOD-like receptor signaling pathway	6/967	157/7206	7.63738474805e-05
ko04010	MAPK signaling pathway	68/967	321/7206	0.000102886395659
ko00604	Glycosphingolipid biosynthesis - ganglio series	8/967	14/7206	0.000145025593308
ko04961	Endocrine and other factor-regulated calcium reabsorption	19/967	59/7206	0.000156244791178
ko04141	Protein processing in endoplasmic reticulum	9/967	184/7206	0.000175434766699
ko04514	Cell adhesion molecules (CAMs)	33/967	130/7206	0.000217167751307
ko03008	Ribosome biogenesis in eukaryotes	1/967	79/7206	0.000328627146447
ko05322	Systemic lupus erythematosus	7/967	151/7206	0.000622254628293
ko04915	Estrogen signaling pathway	32/967	131/7206	0.000633600713709
ko04925	Aldosterone synthesis and secretion	27/967	105/7206	0.000715393796637
ko04020	Calcium signaling pathway	55/967	265/7206	0.000869106158719
ko04540	Gap junction	31/967	128/7206	0.0008975983119
ko05120	Epithelial cell signaling in Helicobacter pylori infection	24/967	92/7206	0.00100313433584
ko05162	Measles	5/967	120/7206	0.00108519873608
ko04022	cGMP-PKG signaling pathway	46/967	216/7206	0.00110704623888
ko04924	Renin secretion	23/967	86/7206	0.00111488211157
ko04064	NF-kappa B signaling pathway	3/967	96/7206	0.0012652520371
ko04971	Gastric acid secretion	25/967	98/7206	0.00139240148741
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	21/967	79/7206	0.00144561624581
ko04740	Olfactory transduction	21/967	80/7206	0.00238915931591
ko04146	Peroxisome	3/967	89/7206	0.00255490358925
ko04014	Ras signaling pathway	55/967	279/7206	0.00295548440108
ko04730	Long-term depression	20/967	78/7206	0.00375683704387
ko00240	Pyrimidine metabolism	5/967	110/7206	0.00426372164471
ko04972	Pancreatic secretion	26/967	111/7206	0.00442291333185
ko04976	Bile secretion	20/967	80/7206	0.00452689936166
ko05205	Proteoglycans in cancer	21/967	271/7206	0.00464159298609
ko05321	Inflammatory bowel disease (IBD)	1/967	56/7206	0.00509025994848
ko01200	Carbon metabolism	7/967	128/7206	0.00556620266248
ko05169	Epstein-Barr virus infection	15/967	206/7206	0.00679388963288
ko04145	Phagosome	34/967	162/7206	0.0069394529248
ko04110	Cell cycle	9/967	145/7206	0.0091235104007
ko04640	Hematopoietic cell lineage	2/967	64/7206	0.00938896181907
ko00533	Glycosaminoglycan biosynthesis - keratan sulfate	6/967	15/7206	0.00978526477733
ko04962	Vasopressin-regulated water reabsorption	15/967	58/7206	0.0103204421799
ko05140	Leishmaniasis	3/967	75/7206	0.0104181648727
ko05414	Dilated cardiomyopathy	25/967	112/7206	0.0109738213098
ko04964	Proximal tubule bicarbonate reclamation	9/967	29/7206	0.0110647498974
ko00330	Arginine and proline metabolism	2/967	61/7206	0.0135371447372
ko04217	Necroptosis	13/967	178/7206	0.0138290720158
ko04214	Apoptosis - fly	3/967	72/7206	0.0146936003055
ko03018	RNA degradation	4/967	84/7206	0.015025575241
ko00620	Pyruvate metabolism	1/967	46/7206	0.0165753958544
ko03420	Nucleotide excision repair	1/967	46/7206	0.0165753958544
ko05145	Toxoplasmosis	8/967	126/7206	0.0169045421355
ko05204	Chemical carcinogenesis	1/967	48/7206	0.017027566286
ko05323	Rheumatoid arthritis	20/967	89/7206	0.0177919139381
ko04371	Apelin signaling pathway	35/967	177/7206	0.0183185440201
ko04391	Hippo signaling pathway - fly	20/967	90/7206	0.0189405257279
ko04072	Phospholipase D signaling pathway	38/967	197/7206	0.0191963346336
ko03022	Basal transcription factors	1/967	44/7206	0.0245793985163
ko05144	Malaria	1/967	45/7206	0.0251949184099
ko00071	Fatty acid degradation	1/967	45/7206	0.0251949184099
ko04626	Plant-pathogen interaction	6/967	18/7206	0.0254909472283
ko05034	Alcoholism	44/967	238/7206	0.0255955338428
ko05146	Amoebiasis	6/967	99/7206	0.0259116354382
ko04930	Type II diabetes mellitus	13/967	54/7206	0.0274628192562
ko00480	Glutathione metabolism	2/967	55/7206	0.027911032022
ko04612	Antigen processing and presentation	4/967	77/7206	0.0286161479415
ko04745	Phototransduction - fly	10/967	38/7206	0.0289827574053
ko04015	Rap1 signaling pathway	50/967	278/7206	0.0307094739463
ko04750	Inflammatory mediator regulation of TRP channels	25/967	122/7206	0.0307422930949
ko04932	Non-alcoholic fatty liver disease (NAFLD)	15/967	182/7206	0.0362269803101
ko00140	Steroid hormone biosynthesis	1/967	41/7206	0.0362754145547
ko04140	Autophagy - animal	13/967	164/7206	0.0365009209113
ko00983	Drug metabolism - other enzymes	1/967	42/7206	0.0372052253402
ko04115	p53 signaling pathway	4/967	74/7206	0.0392472279873
ko00590	Arachidonic acid metabolism	2/967	52/7206	0.0398917647469
ko00561	Glycerolipid metabolism	3/967	63/7206	0.0404179246509
ko00600	Sphingolipid metabolism	3/967	63/7206	0.0404179246509
ko05161	Hepatitis B	14/967	173/7206	0.0412079892974
ko00280	Valine, leucine and isoleucine degradation	2/967	54/7206	0.0416023033289
ko00190	Oxidative phosphorylation	25/967	127/7206	0.0474754531003
ko04950	Maturity onset diabetes of the young	8/967	29/7206	0.0480075466813